Bristol-Myers Squibb (Germany)

Unintended consequences of machine learning in medicine?

Laura McDonald, Sreeram V Ramagopalan, Andrew Cox et al.

2017 · 35 Zit.

Use of Large Language Models and Artificial Intelligence Tools in Works Submitted to <i>Journal of Clinical Oncology</i>

Kathy D. Miller, Emilie Gunn, Angela Cochran et al.

2023 · 13 Zit.

Translating the regulatory landscape of medical devices to create fit‐for‐purpose artificial intelligence (<scp>AI</scp>) cytometry solutions

Goce Bogdanoski, Fabienne Lucas, Wolfgang Kern et al.

2024 · 7 Zit.

341P Artificial intelligence-supported early detection of lung cancer from chest x-ray in routine clinical practice: Real-world, multicenter study across Czech hospitals

Karolína Kvaková, Daniel Kvak, Jakub Dandár et al.

2025 · 0 Zit.

MSR24 AI-Driven Simulation of FDA DCOA Review to Inform Evidence Planning and Regulatory Strategy

Rajdeep Kaur, Sarah M. Donelson, Matthew A. Dixon et al.

2025 · 0 Zit.

282P Impact of artificial intelligence (AI) on follow-up of incidental lung nodules: A US multi-center ambispective study

Jasleen Pannu, N. S. Hill, M. Viseroi et al.

2025 · 0 Zit.

The silent art of leveling up: what I learned from my first crystals

Amy A. Sarjeant

2022 · 0 Zit.